About Isomorphic Labs

Isomorphic Labs applies frontier artificial intelligence to reimagine drug discovery from first principles. The company builds powerful predictive and generative AI models that accelerate the design of new medicines, enabling researchers to explore previously inaccessible chemical landscapes and tackle historically challenging therapeutic targets with extraordinary pace and accuracy. Founded as an Alphabet company and launched from DeepMind, Isomorphic Labs brings together drug discovery experts and machine learning specialists. The team has created a unified drug design engine capable of working across multiple therapeutic areas, moving the field closer to the promise of digital biology.